CR Double-Crane Pharma Unit Passes Shandong Drug Regulator's GMP Inspection

MT Newswires Live

2025/03/04

China Resources Double-Crane Pharmaceutical's (SHA:600062) unit, Dongying Tiandong Pharmaceutical, has passed a Good Manufacturing Practices (GMP) inspection conducted by the Shandong Provincial Food and Drug Administration in China, according to a Shanghai Stock Exchange disclosure on Tuesday.

The inspection, which took place from Dec. 26 to Dec. 31, 2024, focused on the company's manufacturing plant that produces crucial raw drug materials, specifically heparin sodium and nadroparin calcium.

The company's shares rose 1% in recent trade.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2516196586"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2516196586\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2516196586?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-04 12:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2516196586","market":"fut","top_or_hot":-1,"title":"CR Double-Crane Pharma Unit Passes Shandong Drug Regulator's GMP Inspection","media":"MT Newswires Live","content":"<html><body><p> China Resources Double-Crane Pharmaceutical's (SHA:600062) unit, Dongying Tiandong Pharmaceutical, has passed a Good Manufacturing Practices (GMP) inspection conducted by the Shandong Provincial Food and Drug Administration in China, according to a Shanghai Stock Exchange disclosure on Tuesday.</p><p>The inspection, which took place from Dec. 26 to Dec. 31, 2024, focused on the company's manufacturing plant that produces crucial raw drug materials, specifically heparin sodium and nadroparin calcium.</p><p>The company's shares rose 1% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CR Double-Crane Pharma Unit Passes Shandong Drug Regulator's GMP Inspection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCR Double-Crane Pharma Unit Passes Shandong Drug Regulator's GMP Inspection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-04 12:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> China Resources Double-Crane Pharmaceutical's (SHA:600062) unit, Dongying Tiandong Pharmaceutical, has passed a Good Manufacturing Practices (GMP) inspection conducted by the Shandong Provincial Food and Drug Administration in China, according to a Shanghai Stock Exchange disclosure on Tuesday.</p><p>The inspection, which took place from Dec. 26 to Dec. 31, 2024, focused on the company's manufacturing plant that produces crucial raw drug materials, specifically heparin sodium and nadroparin calcium.</p><p>The company's shares rose 1% in recent trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CR","symbol_name":"crane","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2516196586","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2516196586","pubTimestamp":1741063567,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Resources Double-Crane Pharmaceutical's  unit, Dongying Tiandong Pharmaceutical, has passed a Good Manufacturing Practices  inspection conducted by the Shandong Provincial Food and Drug Administration in China, according to a Shanghai Stock Exchange disclosure on Tuesday.The inspection, which took place from Dec. 26 to Dec. 31, 2024, focused on the company's manufacturing plant that produces crucial raw drug materials, specifically heparin sodium and nadroparin calcium.The company's shares rose 1% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600062":"华润双鹤","CR":"crane","BK0175":"白马股","BK4161":"工业机械","BK0010":"央企","BK0028":"国家队","BK0239":"医药制造","BK0185":"二线龙头","BK0188":"融资融券"},"translate_title":"华润双鹤制药单位通过山东省药品监管机构GMP检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600062":0.9,"CR":1},"content_text":"China Resources Double-Crane Pharmaceutical's (SHA:600062) unit, Dongying Tiandong Pharmaceutical, has passed a Good Manufacturing Practices (GMP) inspection conducted by the Shandong Provincial Food and Drug Administration in China, according to a Shanghai Stock Exchange disclosure on Tuesday.The inspection, which took place from Dec. 26 to Dec. 31, 2024, focused on the company's manufacturing plant that produces crucial raw drug materials, specifically heparin sodium and nadroparin calcium.The company's shares rose 1% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}